Cidofovir: To use or not to use?

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 1, 2008, Pages 86-90

  Soma, Marlene A ^a   Albert, David M ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Cidofovir; Human papilloma virus; Laryngeal papillomatosis; Recurrent respiratory papillomatosis; Vistide

Indexed keywords

CIDOFOVIR;

ADJUVANT THERAPY; BREAST ADENOCARCINOMA; CARCINOGENIC ACTIVITY; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; HEALTH HAZARD; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; LONG TERM CARE; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PAPILLOMATOSIS; PATIENT CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CYTOSINE; HUMANS; INJECTIONS, INTRALESIONAL; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PHOSPHONIC ACIDS; RESPIRATORY TRACT NEOPLASMS;

EID: 38149042799     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282f43408     Document Type: Review

References (30)

1. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine]. J Med Virol 1998; 54:219-225.
2. Kurtzman G, Pickel M, Christensen N, Kreider J. Phosphonate nucleoside analogs are potent antipapillomavirus agents in animal models [abstract]. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 17-20 October 1993; New Orleans, USA. Abstract No. 1593.
3. VanCutsem E, Snoeck R, Van Ranst, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol 1995; 45:230-235.
4. Pransky SM, Magit AE, Kearns DB, et al. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999; 125:1143-1148.
5. Chadha NK, James AL. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev 2005; (4):CD005053.
6. Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004; 130:1039-1042.
7. Tasca RA, McCormick M, Clarke R. British Association of Paediatric Otolaryngology members experience with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2006; 20:1183-1187.
8. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999; 36:127-143.
9. De Clercq E. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verh K Acad Geneesk Belg 1996; 58:19-47.
10. De Clercq E, Holy A, Rosenberg I, et al. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986; 323:464-467.
11. Major T, Szarka K, Sziklai I, et al.The characteristic of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 2005; 58:51-55.
12. Wiatrak BJ, Wiatrak DW, Broker TR, et al. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a pediatric population. Laryngoscope 2004; 114:1-23.
13. Wachsman M, Petty BG, Cundy KC, et al. Pharmacokinetics safety and bioavailability of cidofovir in HIV-infected subjects. Antiviral Res 1996; 29:153-161.
14. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 2003; 16:569-596.
15. Chadha NK, James AL. Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. Otolaryngol Head Neck Surg 2007; 136:863-869. Excellent summary of current publications regarding cidofovir use.
16. Naiman AN, Roger G, Gagnieu MC, et al. Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 2004; 114:1151-1156.
17. Dancey DR, Chamberlain DW, Krajden M, et al. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 2000; 118: 1210-1214.
18. Gilead Sciences, Inc., Physician's desk reference. Montvale, New Jersey: Thomson; 2003; pp. 1428-1432.
19. Derkay C. Multi-Disciplinary Task Force on Recurrent Respiratory Papillomas. Cidofovir for recurrent respiratory papillomatosis (RRP): a reassessment of risks. Int J Pediatr Otorhinolaryngol 2005; 69:1465-1467.
20. Wemer RD, Lee JH, Hoffman HT, et al. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005; 114:836-839.
21. Derkay CS, Darrow DH. Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2006; 115:1-11.
22. Derkay CS, Malis DJ, Zalzal G, et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 1998; 108:935-937.
23. Pignatari S, Smith EM, Gray SD, et al. Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol 1992; 101:408-412.
24. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. Arch Otolaryngol Head Neck Surg 2002; 128:425-428.
25. Patel RS, Mackenzie K. Powered laryngeal shavers and laryngeal papillomatosis: a preliminary report. Clin Otolaryngol 2000; 25:358-360.
26. 2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope 2003; 113:139-143.
27. Derkay CS. Task force on recurrent respiratory papillomatosis: a preliminary report. Arch Otolaryngol Head Neck Surg 1995; 121:1386-1391.
28. De Bilderling G, Bodart E, Lawson G, et al. Successful use of intralesional and intravenous cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. J Med Virol 2005; 75:332-335.
29. Cullen RD, Zdanski C. Delivery of cidofovir to respiratory papillomas of the distal trachea. Laryngoscope 2005; 115:552-554.
30. Mandell DL, Arjmand EM, Kay DJ, et al. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2004; 130:1319-1323.